Yuanyuan Wang

1. MEDEN, Anže, ŽNIDARŠIČ, Neža, KNEZ, Damijan, WANG, Yuanyuan, XU, Ziwei, PIŠLAR, Anja, PERDIH, Andrej, KRANJC BREZAR, Simona, GRGUREVIČ, Neža, PAJK, Stane, GOBEC, Stanislav, et al. Pleiotropic prodrugs for both symptomatic and disease-modifying treatment of Alzheimer’s disease : oral presentation. In: MEDEN, Anže (ed.), et al. 15th International Meeting on Cholinesterases : 9th International Conference on Paraoxonases : Brdo pri Kranju, Slovenia, 15-18 September, 2024 : programme and book of abstracts. Ljubljana: Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, 2024. Str. 56-57, or-35. ISBN 978-961-95462-3-9. https://www.chepon2024.com/wp-content/uploads/2024/09/CHEPON2024_Book_of_Abstracts.pdf. [COBISS.SI-ID 208660995]

2. KOŠAK, Urban, KNEZ, Damijan, FERJANČIČ BENETIK, Svit, MASTNAK-SOKOLOV, Peter, PIŠLAR, Anja, HORVAT, Selena, STOJAN, Jure, LV, Bingbing, ZHANG, Weiting, WANG, Yuanyuan, GOBEC, Stanislav, et al. Chiral switch of a butyrylcholinesterase inhibitor for the treatment of Alzheimer's disease. Chemico-biological interactions. [Print ed.]. 2025, vol. 420, [article. no.] 111670, str. 1-15, ilustr. ISSN 0009-2797. https://www.sciencedirect.com/science/article/pii/S000927972500300X, Repository of the University of Ljubljana – RUL , DOI: 10.1016/j.cbi.2025.111670. [COBISS.SI-ID 250780931]
project: The financial support from the Slovenian Research and Innovation Agency (Research Core Funding grants P1-0208, P4-0127, project N1-0277 and bilateral cooperation grant BI-FR/23-24-PROTEUS-002) and by University of Ljubljana grant to SG (funds obtained through an internal call by the University of Ljubljana for the implementation of the preparatory phase of the VIP project were provided by ARIS, under contract no. SN-ZRD/22–27/0510) is gratefully acknowledged. Alexandre Igert, José Dias, Florian Nachon and Xavier Brazzolotto were supported by the French Ministry of Armed Forces (Direction Générale des l’Armement and Service de Santé des Armées; grant NBC-5-C-2316). The grant from China - Central and Eastern European countries University joint education program (founding number 2022248 & 2023282) is acknowledged. The authors acknowledge the ESRF and the French Biology/Health beamline allocation committee for providing the synchrotron radiation beamtime during MX2498, and A07–19, A07-1-19 access. We thank the local contacts A. McCarthy, E. Rivé-Mathieu, and S. Engilberge for their support using beamlines ID30B and BM07-FIP2.

3. MEDEN, Anže, ŽNIDARŠIČ, Neža, KNEZ, Damijan, WANG, Yuanyuan, XU, Ziwei, YANG, Huajing, ZHANG, Weiting, PIŠLAR, Anja, PERDIH, Andrej, KRANJC BREZAR, Simona, GRGUREVIČ, Neža, PAJK, Stane, SUN, Haopeng, GOBEC, Stanislav. Pleiotropic prodrugs for both symptomatic and disease-modifying treatment of Alzheimer’s disease. Acta pharmaceutica sinica B. 2025, vol. 15, no. 9, str. 4807-4828. ISSN 2211-3843. https://www.sciencedirect.com/science/article/pii/S2211383525004605, Repository of the University of Ljubljana – RUL , DOI: 10.1016/j.apsb.2025.07.005. [COBISS.SI-ID 249943299]